Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada

Value Health. 2014 Nov;17(7):A633. doi: 10.1016/j.jval.2014.08.2267. Epub 2014 Oct 26.

Authors

W Herring¹, I Pearson², M Purser¹, H R Nakhaipour³, A Haiderali⁴, S Wolowacz², K Jayasundara³

Affiliations

¹ RTI Health Solutions, Research Triangle Park, NC, USA.
² RTI Health Solutions, Manchester, UK.
³ GlaxoSmithKline, Mississauga, ON, Canada.
⁴ GlaxoSmithKline, Collegeville, PA, USA.

PMID: 27202251
DOI: 10.1016/j.jval.2014.08.2267

No abstract available